HIF

The study shows VCP-mutant astrocytes exhibit hypoxia response activation withou

closed · Rounds: 4 · Score: 0.78 · 2026-04-13

Metabolic Rewiring via SPP1-Induced HIF1α Glycolytic Shift

Score: 0.620 · neuroinflammation · 2026-04-22

**Molecular Mechanism and Rationale** The SPP1 (secreted phosphoprotein 1, osteopontin)-HIF1α metabolic rewiring pathwa

Cell-state stratification is required to resolve Biophysical Determinants Shifti

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: FUS, TDP-43, RNA. Averaging a

ALS-Associated G3BP1 Mutations Shift Phase Separation Equilibrium Toward Aberran

Score: 0.610 · neurodegeneration · 2026-04-22

## Mechanistic Overview ALS-Associated G3BP1 Mutations Shift Phase Separation Equilibrium Toward Aberrant Condensate Sta

Perturbation-first validation should precede therapeutic claims for Biophysical

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro

Intermittent HBOT (2.0 ATA, 60 min, 3x/week) suppresses NLRP3 inflammasome and s

Score: 0.590 · neurodegeneration · 2026-04-25

This hypothesis proposes that HBOT reduces ROS-mediated NF-κB activation and NLRP3 inflammasome assembly, promoting anti

Microglial Replacement and Ontogeny Shift

Score: 0.590 · developmental-neurobiology · 2026-04-21

**Molecular Mechanism and Rationale** The molecular foundation of microglial replacement and ontogeny shift centers on

HIF1A stabilization lowers the activation threshold of circadian-disrupted micro

Score: 0.566 · neuroinflammation · 2026-04-21

## **Molecular Mechanism and Rationale** The molecular mechanism underlying this hypothesis centers on the stabilizatio

Dysregulated microglial glycolysis via HIF1α activation shifts the balance from

Score: 0.520 · neurodegeneration · 2026-04-22

## Mechanistic Overview Dysregulated microglial glycolysis via HIF1α activation shifts the balance from neuroprotective

Shift AQP4 Isoform/OAP Assembly Toward Clearance-Competent Autoantibody-Less-Clu

Score: 0.500 · neurodegeneration · 2026-04-21

## Mechanistic Overview Shift AQP4 Isoform/OAP Assembly Toward Clearance-Competent Autoantibody-Less-Clustered State sta

Moderate hyperoxia (1.5-2.0 ATA) optimally stabilizes HIF-1α to enhance VEGF-med

Score: 0.470 · neurodegeneration · 2026-04-25

This hypothesis claims HBOT at 1.5-2.0 ATA produces sub-lethal oxidative stress that paradoxically stabilizes HIF-1α des

Cdk5/p25-PSD-95 Phosphorylation Disrupts Synaptic Scaffolding and Shifts APP Pro

Score: 0.455 · neurodegeneration · 2026-04-27

Age-dependent p35-to-p25 cleavage activates Cdk5, which phosphorylates PSD-95 S561, disrupting AMPA/NMDA receptor anchor

CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metabolic Reprogramming i

Score: 0.380 · developmental-neurobiology · 2026-04-27

This hypothesis proposes that perinatal immune activation triggers CCR2-dependent recruitment of bone marrow-derived mon

CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metabolic Reprogramming i

Score: 0.351 · developmental-neurobiology · 2026-04-26

This hypothesis proposes that perinatal immune activation triggers a two-phase pathogenic cascade where CCR2-mediated re

P-tau217 Isoform Shift Indicates Mechanistic Transition Point for Cessation Elig

Score: 0.245 · unknown disease · 2026-04-26

Donanemab treatment causes a shift from disease-specific p-tau217 (produced via amyloid-driven kinase activation) toward

C-Terminal Frameshift Protection via RNA-Guided Editing

Score: 0.000 · unknown disease · 2026-04-28

Engineered guide RNAs could direct site-specific adenosine deaminases to prevent C-terminal frameshift mutations that dr